Methods for delivering MBD peptidelinked agent into cells under conditions of cellular stress

Details for Australian Patent Application No. 2005243741 (hide)

Owner Bioexpertise LLC

Inventors Mascarenhas, Desmond; Singh, Baljit K.

Agent Davies Collison Cave

Pub. Number AU-B-2005243741

PCT Pub. Number WO2005/110493

Priority 60/563,676 19.04.04 US; 60/563,141 16.04.04 US; 60/657,826 01.03.05 US

Parent 2002324672

Filing date 18 April 2005

Wipo publication date 24 November 2005

Acceptance publication date 28 January 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 31/7008 (2006.01) - Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine

A61K 31/704 (2006.01)

A61K 31/7048 (2006.01)

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 38/30 (2006.01) Medicinal preparations containing peptides - Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

A61K 39/385 (2006.01) Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 Drugs for specific purposes, not provided for in groups

Event Publications

30 November 2006 PCT application entered the National Phase

  PCT publication WO2005/110493 Priority application(s): WO2005/110493

4 December 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read Methods for delivering MBD peptidelinked agent into cells under conditions of cellular stress

28 January 2010 Application Accepted

  Published as AU-B-2005243741

27 May 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005243742-Blood drawing device

2005243738-Apparatus for filling and refilling a flexible container